DD249479A5 - Verfahren zur herstellung von propionamidin-derivaten - Google Patents

Verfahren zur herstellung von propionamidin-derivaten Download PDF

Info

Publication number
DD249479A5
DD249479A5 DD86294264A DD29426486A DD249479A5 DD 249479 A5 DD249479 A5 DD 249479A5 DD 86294264 A DD86294264 A DD 86294264A DD 29426486 A DD29426486 A DD 29426486A DD 249479 A5 DD249479 A5 DD 249479A5
Authority
DD
German Democratic Republic
Prior art keywords
sulfamyl
guanidinothiazol
formula
propionamidine
alkylation
Prior art date
Application number
DD86294264A
Other languages
German (de)
English (en)
Inventor
Peter Bod
Kalman Harsanyi
Eva Agai
Erik Bogsch
Eva Fekecs
Ferenc Trischler
Gyoergy Domany
Istvan Szabadkai
Bela Hegedues
Original Assignee
�������@������@����������@����@��Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10963968&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD249479(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by �������@������@����������@����@��Kk�� filed Critical �������@������@����������@����@��Kk��
Publication of DD249479A5 publication Critical patent/DD249479A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD86294264A 1985-09-11 1986-09-09 Verfahren zur herstellung von propionamidin-derivaten DD249479A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU853424A HU194845B (en) 1985-09-11 1985-09-11 Process for production of n-sulphamil-3-/2-guanidintiazolil-4-methil-tio/-propion-amidin

Publications (1)

Publication Number Publication Date
DD249479A5 true DD249479A5 (de) 1987-09-09

Family

ID=10963968

Family Applications (1)

Application Number Title Priority Date Filing Date
DD86294264A DD249479A5 (de) 1985-09-11 1986-09-09 Verfahren zur herstellung von propionamidin-derivaten

Country Status (22)

Country Link
US (1) US4835281A (ko)
JP (1) JPH0645609B2 (ko)
KR (1) KR910000237B1 (ko)
CN (1) CN1013674B (ko)
AR (1) AR240319A1 (ko)
AT (1) AT386824B (ko)
AU (1) AU587279B2 (ko)
BE (1) BE905409A (ko)
CA (1) CA1263120A (ko)
DD (1) DD249479A5 (ko)
DK (1) DK169920B1 (ko)
ES (1) ES2001677A6 (ko)
FI (1) FI86423C (ko)
GB (1) GB2180237B (ko)
GE (1) GEP19960471B (ko)
GR (1) GR862308B (ko)
HU (1) HU194845B (ko)
NL (1) NL8602225A (ko)
NO (1) NO163010C (ko)
PT (1) PT83348B (ko)
SE (1) SE8603797L (ko)
SU (1) SU1450743A3 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU194845B (en) * 1985-09-11 1988-03-28 Richter Gedeon Vegyeszet Process for production of n-sulphamil-3-/2-guanidintiazolil-4-methil-tio/-propion-amidin
HU196775B (en) * 1986-08-05 1989-01-30 Richter Gedeon Vegyeszet Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
IL86330A0 (en) * 1987-06-22 1988-11-15 Marga Investigacion Famotidine polymorphic forms and their preparation
US5731442A (en) * 1997-03-11 1998-03-24 Albemarle Corporation Synthesis of thiazole derivatives
US5856500A (en) * 1997-03-11 1999-01-05 Albemarle Corporation Synthesis of thiazole derivatives
AU772188B2 (en) * 1998-11-17 2004-04-08 Nitromed, Inc. Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
US20110143340A1 (en) * 2007-11-01 2011-06-16 Biocept, Inc. Non-invasive isolation of fetal nucleic acid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056143B2 (ja) * 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法
US4808589A (en) * 1982-02-20 1989-02-28 Smith Kline & French Laboratories Limited Pyrimidone derivatives
US4496737A (en) * 1982-09-27 1985-01-29 Merck & Co., Inc. Process for preparing sulfamylamidine antisecretory agents
ES8504157A1 (es) * 1983-10-07 1985-04-01 Inke Sa Procedimiento para la obtencion de (-1amino-3-(((2-((diaminometileno) amino)-4-tiazolil)metil)tio)propilideno)sulfamida
ES8506665A1 (es) * 1984-05-07 1985-08-01 Inke Sa Procedimiento para la obtencion de la 1-amino-3-2-diamino-metilen-amino-4-tiazolil-metil-tio-propiliden-sulfamida.
ES536322A0 (es) * 1984-09-27 1985-08-01 Bioiberica Procedimiento para la obtencion del n-aminosolfenil-3-(((2-guanidin-4-tiazonil)metil)tio) propionamidina
ES536803A0 (es) * 1984-10-17 1985-08-01 Inke Sa Procedimiento para la obtencion de la (1-amino-3(((2-((diamino-metilen) amino)-4-tiazolil)metil)tio)propiliden)sulfamida
HU194845B (en) * 1985-09-11 1988-03-28 Richter Gedeon Vegyeszet Process for production of n-sulphamil-3-/2-guanidintiazolil-4-methil-tio/-propion-amidin
HU193608B (en) * 1985-09-11 1987-11-30 Richter Gedeon Vegyeszet Process for production of new dervatives of n-sulphanol-propion-amidine
JP3751649B2 (ja) * 1994-12-01 2006-03-01 関西ペイント株式会社 自動車外板塗膜の一時保護方法

Also Published As

Publication number Publication date
CN86105909A (zh) 1987-05-13
NO863616L (no) 1987-03-12
GB2180237A (en) 1987-03-25
BE905409A (fr) 1986-12-31
FI86423C (fi) 1992-08-25
AU6256986A (en) 1987-03-12
KR870003078A (ko) 1987-04-15
KR910000237B1 (ko) 1991-01-23
GB2180237B (en) 1989-09-06
AU587279B2 (en) 1989-08-10
GEP19960471B (en) 1996-05-13
NO163010B (no) 1989-12-11
US4835281A (en) 1989-05-30
ES2001677A6 (es) 1988-06-01
SE8603797L (sv) 1987-03-12
FI863657A0 (fi) 1986-09-10
PT83348B (pt) 1988-07-29
HU194845B (en) 1988-03-28
DK434586A (da) 1987-03-12
DK434586D0 (da) 1986-09-10
NL8602225A (nl) 1987-04-01
ATA243486A (de) 1988-03-15
AR240319A1 (es) 1990-03-30
NO863616D0 (no) 1986-09-10
FI863657A (fi) 1987-03-12
NO163010C (no) 1990-03-21
GR862308B (en) 1987-01-02
PT83348A (pt) 1986-10-01
CN1013674B (zh) 1991-08-28
FI86423B (fi) 1992-05-15
JPH0645609B2 (ja) 1994-06-15
SE8603797D0 (sv) 1986-09-10
DK169920B1 (da) 1995-04-03
AT386824B (de) 1988-10-25
JPS6296481A (ja) 1987-05-02
HUT42766A (en) 1987-08-28
GB8621742D0 (en) 1986-10-15
CA1263120A (en) 1989-11-21
SU1450743A3 (ru) 1989-01-07

Similar Documents

Publication Publication Date Title
DE2322880C2 (de) 4-(Imidazolin-2-ylamino)-2,1,3-benzothiadiazole und Verfahren zu deren Herstellung
DE1668420A1 (de) N-substituierte Perfluoralkylsulfonamide
DE2457911A1 (de) Verfahren zur herstellung von chinazolinen
DE2505297B2 (de) Verfahren zur Herstellung von in 2- und 6-Stellung des Phenylkerns substituierten 2-Phenylamino-2-imidazolin-Derivaten
DE2826452A1 (de) Verfahren zur herstellung von substituierten guanidinen
DD249479A5 (de) Verfahren zur herstellung von propionamidin-derivaten
DE941288C (de) Verfahren zur Herstellung substituierter 2-Imino-4-thiazoline oder von Salzen derselben bzw. von substituierten 2-Aminothiazolen
DE1770658A1 (de) N-Hydroxi-benzimidazole,ihre Herstellung und Verwendung als Herbicide
DE1795344B2 (de) Verfahren zur herstellung von 3-aminoisothiazolen
DE915809C (de) Verfahren zur Herstellung von heterocyclischen Sulfonamiden
DE2523279A1 (de) Verfahren zur herstellung von 3-trichlormethyl-5-aethoxy-1,2,4-thiadiazol
DE946804C (de) Verfahren zur Herstellung von schwefelhaltigen Abkoemmlingen der Barbitursaeure
DE2166270C3 (de) Nicotinoylaminoäthansulfonyl-2amino-thiazol
DE2065698C3 (de) Verfahren zur Herstellung von 2-Isopropyl-6-methyl-4(3H)-pyrimidon
DE2536951A1 (de) Triazapentadiene, verfahren zu ihrer herstellung und ihre verwendung als milbenmittel und insektizide
DE2208434C2 (de) Substituierte 2-(N-Furylmethyl-N-phenyl-amino)-2-imidazoline, deren Säureadditionssalze, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
DE1695092B2 (de) N-(4-Sulfonamidophenyl)-a-alkylsuccinimide und deren Salze mit Basen, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen
AT326101B (de) Verfahren zur herstellung von neuen substituierten formylazapentadiennitrilen sowie von deren säureadditionssalzen
DE737931C (de) Verfahren zur Herstellung von 2, 4-Diaminochinazolin
AT373588B (de) Verfahren zur herstellung von neuen substituierten 1-benzoyl-2-phenylimino-imidazolidinen und von deren salzen
AT360520B (de) Verfahren zur herstellung von neuen thiazoli- dinderivaten und ihren salzen
AT400146B (de) Verfahren zur herstellung von 1-(2-((5-
CH641174A5 (de) Verfahren zur herstellung von n-(4'-chlor-3'-sulfamoyl-benzolsulfonyl)-n-methyl-2-aminomethyl-2-methyl-tetrahydrofuran.
DE3710254A1 (de) Antiulcusmittel
DE2019719C3 (de) 1,3,4-Substituierte 5-Dimethylaminouracile und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20060910